Key facts
- · Type: Amendment first sale 2025-07-17 · Amount sold: $71K · Total offering: $1.74M · SEC filing
- · Type: New offering · Amount sold: $0 · Total offering: $1.74M · SEC filing
- · Type: Amendment first sale 2023-12-29 · Amount sold: $417K · Total offering: $2.18M · SEC filing
- · Type: New offering · Amount sold: $0 · Total offering: $2.18M · SEC filing
- · Type: Amendment first sale 2019-03-13 · Amount sold: $1.49M · Total offering: $2M · SEC filing
Based
CAMBRIDGE, MASSACHUSETTS
CAMBRIDGE, MASSACHUSETTS
Industry group
Pharmaceuticals
Pharmaceuticals
Filings
5
5
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-05-20 | Amendment first sale 2025-07-17 | $71K | $1.74M | SEC filing |
| 2025-05-14 | New offering | $0 | $1.74M | SEC filing |
| 2025-02-11 | Amendment first sale 2023-12-29 | $417K | $2.18M | SEC filing |
| 2023-10-11 | New offering | $0 | $2.18M | SEC filing |
| 2023-01-26 | Amendment first sale 2019-03-13 | $1.49M | $2M | SEC filing |
Want the whole picture on Sea Pharmaceuticals, LLC?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sea Pharmaceuticals, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sea Pharmaceuticals, LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Every figure here is read from Sea Pharmaceuticals, LLC's own filings with the SEC. The people those filings name are on the team page.